D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 120 Citations 53,145 784 World Ranking 1585 National Ranking 52

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Psychiatry
  • Schizophrenia

Psychiatry, Antipsychotic, Internal medicine, Schizophrenia and Bipolar disorder are his primary areas of study. His studies in Psychiatry integrate themes in fields like Young adult and Randomized controlled trial. His Antipsychotic research integrates issues from Tolerability, Adverse effect, Pharmacology, Intensive care medicine and Weight gain.

His biological study spans a wide range of topics, including Placebo, Clozapine and Atypical antipsychotic. His Schizophrenia research is multidisciplinary, incorporating perspectives in Abdominal obesity, Quality of life, Polypharmacy, Mental illness and Major depressive disorder. His Bipolar disorder research is multidisciplinary, incorporating elements of Psychological intervention and Mood.

His most cited work include:

  • Physical illness in patients with severe mental disorders.I. Prevalence, impact of medications and disparities in health care (1300 citations)
  • Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. (740 citations)
  • Metabolic and cardiovascular adverse effects associated with antipsychotic drugs (591 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Psychiatry, Internal medicine, Antipsychotic, Schizophrenia and Meta-analysis. He works mostly in the field of Psychiatry, limiting it down to topics relating to MEDLINE and, in certain cases, Intensive care medicine, as a part of the same area of interest. While the research belongs to areas of Internal medicine, he spends his time largely on the problem of Olanzapine, intersecting his research to questions surrounding Quetiapine and Risperidone.

His Antipsychotic research is multidisciplinary, relying on both Discontinuation, Adverse effect, Polypharmacy, Weight gain and Pediatrics. His study on Clozapine, Positive and Negative Syndrome Scale and Schizoaffective disorder is often connected to In patient as part of broader study in Schizophrenia. His work deals with themes such as Odds ratio and Relative risk, which intersect with Meta-analysis.

He most often published in these fields:

  • Psychiatry (67.64%)
  • Internal medicine (46.76%)
  • Antipsychotic (38.10%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (46.76%)
  • Antipsychotic (38.10%)
  • Schizophrenia (36.02%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Antipsychotic, Schizophrenia, Psychiatry and Adverse effect. Christoph U. Correll has researched Internal medicine in several fields, including Gastroenterology and Olanzapine. Christoph U. Correll interconnects Neuropsychopharmacology, Incidence, MEDLINE, Rating scale and Aripiprazole in the investigation of issues within Antipsychotic.

His research in Schizophrenia intersects with topics in Psychosis, Randomized controlled trial, Cognition and Clinical psychology. His study in Schizophrenia and Anxiety falls within the category of Psychiatry. Christoph U. Correll works mostly in the field of Adverse effect, limiting it down to concerns involving Placebo and, occasionally, Exacerbation.

Between 2019 and 2021, his most popular works were:

  • How mental health care should change as a consequence of the COVID-19 pandemic. (184 citations)
  • How mental health care should change as a consequence of the COVID-19 pandemic. (184 citations)
  • Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment. (29 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Schizophrenia
  • Psychiatry

His scientific interests lie mostly in Antipsychotic, Internal medicine, MEDLINE, Schizophrenia and Psychiatry. The Antipsychotic study combines topics in areas such as Clinical trial, Hazard ratio, Major depressive disorder, Medical prescription and Pediatrics. His studies in Internal medicine integrate themes in fields like Prediabetes and Ziprasidone.

His MEDLINE research incorporates elements of Dosing and Intensive care medicine. His Schizophrenia research integrates issues from Adverse effect, Psychosis and Randomized controlled trial. His research integrates issues of Treatment outcome and Emotional expression in his study of Psychiatry.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Physical illness in patients with severe mental disorders.I. Prevalence, impact of medications and disparities in health care

Marc De Hert;Christoph U. Correll;Julio Bobes;Marcelo Cetkovich-Bakmas.
World Psychiatry (2011)

1924 Citations

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.

Christoph U. Correll;Peter Manu;Vladimir Olshanskiy;Barbara Napolitano.
JAMA (2009)

1062 Citations

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

Marc De Hert;Johan Detraux;Ruud van Winkel;Weiping Yu.
Nature Reviews Endocrinology (2012)

867 Citations

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.

Christoph U. Correll;Stefan Leucht;John M. Kane.
American Journal of Psychiatry (2004)

856 Citations

Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level

Marc De Hert;Dan Cohen;Julio Bobes;Marcelo Cetkovich-Bakmas.
World Psychiatry (2011)

804 Citations

Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls.

Christoph U. Correll;Marco Solmi;Nicola Veronese;Beatrice Bortolato.
World Psychiatry (2017)

742 Citations

Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.

Stefan Leucht;Thomas R.E. Barnes;Werner Kissling;Rolf R. Engel.
American Journal of Psychiatry (2003)

666 Citations

Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder

Christoph U. Correll;Johan Detraux;Jan De Lepeleire;Marc De Hert.
World Psychiatry (2015)

588 Citations

Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program

John M. Kane;Delbert G. Robinson;Nina R. Schooler;Kim T. Mueser.
American Journal of Psychiatry (2016)

535 Citations

Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis

Davy Vancampfort;Brendon Stubbs;Alex J Mitchell;Marc De Hert.
World Psychiatry (2015)

516 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Christoph U. Correll

Brendon Stubbs

Brendon Stubbs

King's College London

Publications: 366

Davy Vancampfort

Davy Vancampfort

KU Leuven

Publications: 181

Patrick D. McGorry

Patrick D. McGorry

University of Melbourne

Publications: 138

Joseph Firth

Joseph Firth

University of Manchester

Publications: 130

Alison R. Yung

Alison R. Yung

University of Melbourne

Publications: 129

Merete Nordentoft

Merete Nordentoft

University of Copenhagen

Publications: 117

Gary Remington

Gary Remington

Centre for Addiction and Mental Health

Publications: 116

John M. Kane

John M. Kane

Feinstein Institute for Medical Research

Publications: 115

Michael Berk

Michael Berk

Deakin University

Publications: 115

Paolo Fusar-Poli

Paolo Fusar-Poli

South London and Maudsley NHS Foundation Trust

Publications: 108

Eduard Vieta

Eduard Vieta

University of Barcelona

Publications: 93

Philip McGuire

Philip McGuire

King's College London

Publications: 93

Oliver D. Howes

Oliver D. Howes

King's College London

Publications: 92

Philip B. Ward

Philip B. Ward

UNSW Sydney

Publications: 79

Stefan Leucht

Stefan Leucht

Technical University of Munich

Publications: 78

Roger S. McIntyre

Roger S. McIntyre

University Health Network

Publications: 78

Something went wrong. Please try again later.